Your new experience awaits. Try the new design now and help us make it even better

MINI REVIEW article

Front. Physiol.

Sec. Exercise Physiology

Volume 16 - 2025 | doi: 10.3389/fphys.2025.1667238

Reframing SpO₂ Tolerance as a Physiological Switch: Implications for Hypoxic Adaptation and Exercise Regulation

Provisionally accepted
Enomoto  YuriEnomoto Yuri*Hui-Yu  ChungHui-Yu Chung*Fu-Shih  ChenFu-Shih Chen
  • Nihon Pharmaceutical University, Toyko, Japan

The final, formatted version of the article will be published soon.

Blood oxygen saturation (SpO₂) is a widely used oxygenation index in clinical and physiological settings. However, recent phenomena, such as asymptomatic hypoxia in COVID-19 and the superior performance of athletes in high-altitude conditions under hypoxia, have highlighted the significant variability in individual tolerance to blood oxygen saturation. Age, health status, disease, and hypoxic adaptation influence it. This brief review introduces the concept of the SpO₂ switch as a dynamic. We also proposed a physiological compensatory response of SpO₂ switch to SpO₂ criticality that triggers compensatory responses, including ventilatory, autonomic, cardiovascular, and metabolic adaptations. Furthermore, individuals can exhibit markedly different responses to hypoxia at the same SpO₂ value. It reflects a "threshold switch mechanism" driven by an individual's internal physiological settings. This suggests that the SpO₂ value demonstrates the onset of hypoxia symptoms and reacts to the body's difference in compensatory capacity. This reconceptualisation shifts the focus from static thresholds to dynamic response analysis, offering new perspectives for precision health, mountain medicine, and personalised risk assessment of hypoxia.

Keywords: SpO₂ switch, physiological switch, Hypoxia Adaptation, autonomic nervous system regulation, Threshold response, Intermittent Hypoxia Training, SpO₂ criticality

Received: 16 Jul 2025; Accepted: 26 Aug 2025.

Copyright: © 2025 Yuri, Chung and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Enomoto Yuri, Nihon Pharmaceutical University, Toyko, Japan
Hui-Yu Chung, Nihon Pharmaceutical University, Toyko, Japan

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.